LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Top News  :  Biocon gets EMA regulator nod for proposed biosimilar trastuzumab, pegfilgrastim

Biocon gets EMA regulator nod for proposed biosimilar trastuzumab, pegfilgrastim (01-Dec-2017)

Mylan N.V. and Biocon announced that the European Medicines Agency (EMA) has accepted for review Mylan's Marketing Authorization Applicat- ions (MAA) for proposed biosimilar trastuzumab and proposed biosimilar pegfilgrastim. Trastuzumab is used to treat certain HER2-positive breast and gastric cancers. Pegfilgrastim is used to reduce the duration of neutropenia (low count of neutrophils, a type of white blood cells) and the incidence of fever associated with neutropenia in adult patients treated with chemotherapy in certain types of cancer.

EMA acceptance of the submissions follows an earlier withdrawal of both applications in response to an audit conducted by the European inspecting authority of Biocon's drug product facility. Biocon has completed the Corrective and Preventive Actions (CAPAs) outlined as a result of the audit observations. The CAPAs will be confirmed during re-inspection, which will be completed as part of the regulatory review process.

Good Manufacturing Practice (GMP) compliance certificates for Biocon's two drug substance manufacturing facilities in Bangalore have been issued previously. Approval of these sites is key in the development and approval process as drug substance manufacture is core to the production of the actual biologic product in GMP compliance.

Biocon is India's largest and Asia's leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Top News Today
Captain Polyplast wins 'Star Performer Award 2017-18'
(25-Apr-2018)

Captain Polyplast wins Captain Polyplast has won 'Star Performer Award ' from Indian oil Corporation for achieving highest sales of Polymer during the financial year 2017-18 among new appointed DCA.Captain Polyplast, an ISO......click on news to read complete article.

RIL's telecom arm adds 8.74 million subscribers in February
(25-Apr-2018)

RILReliance Industries' (RIL) telecom arm - Reliance Jio Infocomm (Jio) has added 8.74 million customers in February, taking its market share to 15.31% up from 14.62% in January, 13.71% in December, 13.08%......click on news to read complete article.

DCM Shriram gets nod for investment proposal, capacity expansion at Kota plant
(25-Apr-2018)

DCM Shriram gets nod for investment proposal, capacity expansion at Kota plantDCM Shriram has received an approval for the investment proposal of PVC - Replacement of Polymerisers with Capacity Expansion at company's Plant at Kota. The Board of Directors of the company in their......click on news to read complete article.

International Stock News
Asian markets trade lower in early deals
(25-Apr-2018)

Asian markets trade lower in early dealsAll the Asian markets are trading in red terrain in early deals following the overnight sell-off on Wall Street. Warnings on profit outlook from bellwether U.S. companies and worries about rising bond......click on news to read complete article.

US markets closed lower; rising bond yields spook investors
(25-Apr-2018)

US markets closed lower; rising bond yields spook investorsThe US markets closed lower on Tuesday, led by a selloff in industrials, materials and technology shares. The selling pressure came after the 10-year Treasury yield briefly touched the psychologically......click on news to read complete article.

Asian markets trade mostly in red in early deals on Tuesday
(24-Apr-2018)

Asian markets trade mostly in red in early deals on TuesdayMost of the Asian equity indices are trading lower in the early deals on Tuesday as a deluge of US government debt this week and the specter of inflation and a higher fiscal deficit drove US borrowing......click on news to read complete article.

 

     
  
Recent Top News News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.